Inhibition of sickle erythrocyte adhesion to immobilized thrombospondin by von Willebrand factor under dynamic flow conditions

Blood

Volumn 89, Issue 7, 1997, Pages 2560-2567

  Barabino, Gilda A ^a   Wise, Robert J ^b   Woodbury, Valerie A ^b   Zhang, Beibing ^b   Bridges, Kenneth A ^b   Hebbel, Robert P ^b   Lawler, Jack ^b   Ewenstein, Bruce M ^b  

^a Northeastern University   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; ERYTHROCYTE ADHESIVENESS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN IMMOBILIZATION; SICKLE CELL ANEMIA;

EID: 0030952912     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2560     Document Type: Article

References (62)

1. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW: Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: Possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest 65:154, 1980
2. Hebbel RP, Mohandas N: Sickle cell adherence, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 217
3. Kaul DK, Fabry ME, Nagel RL: Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications. Proc Natl Acad Sci USA 86:3356, 1989
4. Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden M: Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood 70:152, 1987
5. Hebbel RP, Boogaerts MA, Eaton JW, Steinberg MH: Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med 302:992, 1980
6. Mohandas N, Evans E: Sickle erythrocyte adherence to vascular endothelium. J Clin Invest 76:1605, 1985
7. Sugihara K, Sugihara T, Mohandas N, Hebbel RP: Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood 80:2634, 1992
8. Brittain HA, Eckman JR, Wick TM: Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 120:538, 1992
9. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM: Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet-activation in sickle cell vasoocclusion. Blood 81:2137, 1993
10. Wick TM, Moake JL, Udden MM, Eskin SG, Sears DA, McIntire LV: Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest 80:905, 1987
11. Wick TM, Moake JL, Udden MM, McIntire LV: Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells. Am J Hematol 42:284, 1993
12. Kaul DK, Nagel RL, Chen D, Tsai HM: Sickle erythrocyte-endothelial interactions in microcirculation: The role of von Willebrand factor and implications for vasoocclusion. Blood 81:2429, 1993
13. Adams JC, Tucker RP, Lawler J: The Thrombospondin Gene Family. Austin, TX, R.G. Landes, 1995
14. Bornstein P: Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J Cell Biol 130:503, 1995
15. Mosher DF, Doyle MJ, Jaffe EA: Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol 93:343, 1982
16. Reinders JH, deGroot PG, Dawes J, Hunter NR, van Heugten HA, Zandbergen J, Gonsalves MD, van Mourik JA: Comparison of secretion and subcellular localization of von Willebrand protein with that of thrombospondin and fibronectin in cultured human vascular endothelial cells. Biochim Biophys Acta 844:306, 1985
17. Lawler J, Hynes RO: The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 103:1635, 1986
18. Baenziger NL, Brodie GN, Majerus PW: Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem 247:2723, 1972
19. Ruggeri ZM, Zimmerman TS: The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57:1140, 1981
20. Sadler JE: von Willebrand factor. J Biol Chem 266:22777, 1991
21. Jaffe EA, Hoyer LW, Nachman RL: Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 52:2757, 1973
22. Nachman R, Levine R, Jaffe EA: Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest 60:914, 1977
23. Levine JD, Harlan JM, Harker LA, Joseph ML, Counts RB: Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture. Blood 60:531, 1982
24. Hamilton KK, Sims PJ: Changes in cytosolic Ca2+ associated with von Willebrand factor release in endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1. J Clin Invest 79:600, 1987
25. Datta YH, Romano M, Jacobson BC, Golan DE, Serhan CN, Ewenstein BM: Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. Circulation 92:3304, 1995
26. Sporn LA, Marder VJ, Wagner DD: Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 46:185, 1986
27. Ewenstein BM, Warhol MJ, Handin RI, Pober JS: Composition of the vWF storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol 104:1423, 1987
28. Fabry ME, Fine E, Rajanayagam V, Factor SM, Gore J, Sylla M, Nagel RL: Demonstration of endothelial adhesion of sickle cells in vivo: A distinct role for deformable sickle cell discocytes. Blood 79:1602, 1992
29. Hillery CA, Ming CD, Montgomery RR, Scott JP: Increased adhesion of erythrocytes to components of the extracellular matrix: Isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. Blood 87:4879, 1996
30. Joneckis CC, Shock DD, Cunningham ML, Orringer EP, Parise LV: Glycoprotein VI-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions. Blood 87:4862, 1996
31. Merkel KH, Ginsberg PL, Parker JCJ, Post MJ: Cerebrovascular disease in sickle cell anemia: A clinical, pathological and radiological correlation. Stroke 9:45, 1978
32. Klug PP, Kaye N, Jensen WN: Endothelial cell and vascular damage in the sickle cell disorders. Blood Cells 8:175, 1982
33. Sowemimo-Coker SO, Meiselman HJ, Francis RB: Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 31:263, 1989
34. Lawler J, Derick LH, Connolly JE, Chen JH, Chao FC: The structure of human platelet thrombospondin. J Biol Chem 260:3762, 1985
35. Legrand C, Thibert V, Dubernard V, Bégault B, Lawler J: Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: Modulation of platelet aggregation. Blood 79:1995, 1992
36. Bonthron DT, Orr EC, Mitsock LM, Ginsburg D, Handin RI, Orkin SH: Nucleotide sequence of pre-pro-von Willebrand factor cDNA. Nucleic Acids Res 14:7125, 1986
37. Wise RJ, Dorner AJ, Krane M, Pittman DD, Kaufman RJ: The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem 266:21948, 1991
38. Cruz MA, Yuan H, Lee JR, Wise RJ, Handin RI: Interaction of the von Willebrand factor (vWF) with collagen: Colocalization of recombinant vWF-A domain polypeptides. J Biol Chem 270:10822, 1995
39. Agbanyo FR, Sixma JJ, deGroot PG, Languino LR, Plow EF: Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. J Clin Invest 92:288, 1993
40. 1-integrin expression on sickle reticulocytes: Vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 82:1891, 1993
41. Gee BE, Platt OS: Sickle reticulocytes adhere to VCAM-1. Blood 85:268, 1995
42. Natarajan M, Udden MM, McIntire LV: Adhesion of sickle red blood cells and damage to interleukin-1β stimulated endothelial cells under flow in vitro. Blood 87:4845, 1996
43. Kucukcelebi A, Barmatoski SP, Barnhart MI: Interactions between vessel wall and perfused sickled erythrocytes: Preliminary observations. Scan Electron Microsc 3:243, 1980
44. Garcia JG, Siflinger-Birnboim A, Bizios R, DelVecchio PJ, Fenton JW, Malik AB: Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 128:96, 1986
45. Browne PV, Mosher DF, Steinberg MH, Hebbel RP: Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. Am J Hematol 51:296, 1996
46. Switalska HI, Niewiarowski S, Tuszynski GP, Rucinski B, Schmaier AH, Morinelli TA: Radioimmunoasay of human platelet thrombospondin: Different patterns of thrombospondin and β-thromboglobulin antigen secretion and clearance from the circulation. J Lab Clin Med 106:690, 1985
47. de Groot PG, Verweij CL, Nawrath PP, deBoer HC, Stern DM, Sixma JJ: Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix towards platelets. Arterioscler Thromb 7:605, 1987
48. Reinders JH, Vervoorn RC, Verweij CL, van Mourik JA, deGroot PG: Perturbation of cultured human vascular endothelial cells by phorbol ester or thrombin alters the cellular von Willebrand factor distribution. J Cell Physiol 133:79, 1987
49. Schorer AE, Moldow CF, Rick ME: Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells. Br J Haematol 67:193, 1987
50. Tannenbaum SH, Rick ME, Shafer B, Gralnick HR: Subendothelial matrix of cultured endothelial cells contains fully processed high molecular weight von Willebrand factor. J Lab Clin Med 113:372, 1989
51. Wu Y-P, van Breugel HH, Lankhof H, Wise RJ, Handin RI, de Groot PG, Sixma JJ: Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor. Arterioscler Thromb Vasc Biol 16:611, 1996
52. Asch AS, Tepler J, Silbiger S, Nachman RL: Cellular attachment to thrombospondin. Cooperative interaction between receptor systems. J Biol Chem 266:1740, 1991
53. Adams JC, Lawler J: Diverse mechanisms for cell attachment to platelet thrombospondin. J Cell Sci 104:1061, 1993
54. Asch AS, Nachman RL: Thrombospondin: Phenomenology to function. Prog Hemost Thromb 89:157, 1989
55. Mumby SM, Raugi GJ, Bornstein P: Interactions of thrombospondin with extracellular matrix proteins: Selective binding to type V collagen. J Cell Biol 98:646, 1984
56. Lahav J, Lawler J, Gimbrone MA: Thrombospondin interactions with fibronectin and fibrinogen. Mutual inhibition in binding. Eur J Biochem 145:151, 1984
57. Lahav J, Schwartz MA, Hynes RO: Analysis of platelet adhesion using radioactive chemical crosslinking reagent: Interaction of thrombospondin with fibronectin and collagen. Cell 31:253, 1982
58. Leung LL, Nachman RL: Complex formation of platelet thrombospondin with fibrinogen. J Clin Invest 70:542, 1982
59. Meyer D, Girma JP: von Willebrand factor: Structure and function. Thromb Haemost 70:99, 1993
60. Ugarova T, Agbanyo FR, Plow EF: Conformational changes in adhesive proteins modulate their adhesive function. Thromb Haemost 74:253, 1995
61. Pottinger BE, Read RC, Paleolog EM, Higgins PG, Pearson JD: von Willebrand factor is an acute phase reactant in man. Thromb Res 53:387, 1989
62. Ewenstein BM, Jacobson BC, Birch KA: Regulated secretion in vascular endothelium, in Wong PY-K, Serhan CN (eds): Cell-cell Interactions in the Release of Inflammatory Mediators. New York, NY, Plenum, 1991, p 141